Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001209191-24-000782

SVP, Gen Counsel & Corp Sec sold 1,667 shares at an average $63.93 ($106,579)

  • SVP, Gen Counsel & Corp Sec acquired 1,667 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eydelman Mikhail SVP, Gen Counsel & Corp Sec 2024-01-02 Option exercise 10b5-1 +1,667 $21.41 $35,690 22,377 D: show line 1 in the form
Eydelman Mikhail SVP, Gen Counsel & Corp Sec 2024-01-02 Sale 10b5-1 −141 $62.91 $8,871 22,236 D: show line 2 in the form
Eydelman Mikhail SVP, Gen Counsel & Corp Sec 2024-01-02 Sale 10b5-1 −598 $63.59 $38,029 21,638 D: show line 3 in the form
Eydelman Mikhail SVP, Gen Counsel & Corp Sec 2024-01-02 Sale 10b5-1 −928 $64.31 $59,680 20,710 D: show line 4 in the form
Open-market sales · 1,667 sh · avg $63.93 · $106,579

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Eydelman Mikhail SVP, Gen Counsel & Corp Sec 2024-01-02 Option exercise · Stock Option (right to buy) 10b5-1 +1,667 193,333 D: show line 5 in the form
Loading xslF345X05/doc4.xml…